Keith Craig, Non Executive Director, bought 5,037 shares in the company on the 9th March 2020 at a price of 394.83p. The Director now holds...

Citigroup today upgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to buy (from neutral) and raised its price target to 2150p (from 1980p).

Broker...

Mikheil Gomarteli, Director, sold 27,623 shares in the company on the 4th March 2020 at a price of 1665.00p. The Director now holds 101,795 shares....

Bill Holland, Non Executive Director, bought 6,000 shares in the company on the 10th March 2020 at a price of 307.24p. The Director now holds...

Matt Timmins, Chief Executive Officer, bought 11,605 shares in the company on the 10th March 2020 at a price of 171.40p. The Director now holds...

Martin Towers, Chairman, bought 20,000 shares in the company on the 9th March 2020 at a price of 199.97p. The Director now holds 180,815 shares....

David Tyler, Chairman, bought 50,000 shares in the company on the 9th March 2020 at a price of 170.90p. The Director now holds 127,370 shares....

Vivien Gould, Non Executive Director, bought 750 shares in the company on the 9th March 2020 at a price of 622.00p. The Director now holds...

Javier Ferrán, Chairman, bought 314 shares in the company on the 10th March 2020 at a price of 2633.00p. The Director now holds 232,563 shares....

Goldman Sachs today reaffirms its buy investment rating on Royal Bank of Scotland Group (The) PLC (LON:RBS) and cut its price target to 280p (from...